Filing Details
- Accession Number:
- 0001209191-23-051073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-02 16:23:09
- Reporting Period:
- 2023-09-28
- Accepted Time:
- 2023-10-02 16:23:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398595 | A Alexander Fitzpatrick | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-28 | 40,000 | $3.62 | 42,969 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-09-29 | 46,258 | $3.78 | 89,227 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.64, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2023.
- The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Billionaire Hedge Funds
